Hersey Distinguished Professor of the Theory and Practice of Physic, Brigham and Women's Hospital
Cardiology
Dr. Eugene Braunwald, MD
Eugene Braunwald practices Cardiology. He researched medicine at Mount Sinai School of Medicine. He over the years received 2 awards: "Elected Member" and "Whos Who in Medicine and Healthcare". Eugene Braunwald, MD is a published doctor and has 73 publications published. The lastest was: 'Platelet Inhibition With Ticagrelor 60 mg Versus 90 mg Twice Daily in the PEGASUS-TIMI 54 Trial.'
Publications
- Efficacy and Safety of Vorapaxar With and Without a Thienopyridine for Secondary Prevention in Patients With Previous Myocardial Infarction and No History of Stroke or...
- Causes of late mortality with dual antiplatelet therapy after coronary stents.
- Cardiovascular Outcomes of Patients in SAVOR-TIMI 53 by Baseline Hemoglobin A1c.
- Ischaemic risk and efficacy of ticagrelor in relation to time from P2Y12 inhibitor withdrawal in patients with prior myocardial infarction: insights from PEGASUS-TIMI 54.
- Saxagliptin and Cardiovascular Outcomes in Patients With Type 2 Diabetes and Moderate or Severe Renal Impairment: Observations From the SAVOR-TIMI 53 Trial.
- Vorapaxar in Patients With Diabetes Mellitus and Previous Myocardial Infarction: Findings From the Thrombin Receptor Antagonist in Secondary Prevention of Atherothromb...
- Genetic risk, coronary heart Disease events, and the clinical benefit of statin therapy: an analysis of primary and secondary prevention trials.
- Galectin-3 in Heart Failure With Preserved Ejection Fraction: A RELAX Trial Substudy (Phosphodiesterase-5 Inhibition to Improve Clinical Status and Exercise Capacity i...
- Long-Term Use of Ticagrelor in Patients with Prior Myocardial Infarction.
- Association between edoxaban dose, concentration, anti-Factor Xa activity, and outcomes: an analysis of data from the randomised, double-blind ENGAGE AF-TIMI 48 trial.
- Genetics and the clinical response to warfarin and edoxaban: findings from the randomised, double-blind ENGAGE AF-TIMI 48 trial.
- Prognostic Implications of Low Level Cardiac Troponin Elevation Using High-Sensitivity Cardiac Troponin T.
- Edoxaban vs. warfarin in vitamin K antagonist experienced and naive patients with atrial fibrillationâ
- New Ischemic Stroke and Outcomes With Vorapaxar Versus Placebo: Results From the TRA 2°P-TIMI 50 Trial.
- Coronary Stent Thrombosis With Vorapaxar Versus Placebo: Results From the TRA 2°P-TIMI 50 Trial.
- Twelve or 30 Months of Dual Antiplatelet Therapy after Drug-Eluting Stents.
- Decongestion Strategies and Renin-Angiotensin-Aldosterone System Activation in Acute Heart Failure.
- Effect of ranolazine on atrial fibrillation in patients with non-ST elevation acute coronary syndromes: observations from the MERLIN-TIMI 36 trial.
- Effect of darapladib on major coronary events after an acute coronary syndrome: the SOLID-TIMI 52 randomized clinical trial.
- Recognizing worsening chronic heart failure as an entity and an end point in clinical trials.
- Resting Ventricular-Vascular Function and Exercise Capacity in Heart Failure With Preserved Ejection Fraction: A RELAX Trial Ancillary Study.
- The ten advances that have defined modern cardiology.
- New oral anticoagulants in patients with atrial fibrillation - Authors'reply.
- GLP-1 Agonist Therapy for Advanced Heart Failure With Reduced Ejection Fraction: Design and Rationale for the Functional Impact of GLP-1 for Heart Failure Treatment St...
- Prasugrel Versus Clopidogrel in Patients With ST-Segment Elevation Myocardial Infarction According to Timing of Percutaneous Coronary Intervention: A TRITON-TIMI 38 Su...
- Cerebrovascular Events in 21 105 Patients With Atrial Fibrillation Randomized to Edoxaban Versus Warfarin: Effective Anticoagulation With Factor Xa Next Generation in ...
- Responsiveness to loop diuretics in heart failure.
- Fibroblast Growth Factor-23, Cardiovascular Prognosis, and Benefit of Angiotensin-Converting Enzyme Inhibition in Stable Ischemic Heart Disease.
- Angiographic Outcomes With Early Eptifibatide Therapy in Non-ST-Segment Elevation Acute Coronary Syndrome (from the EARLY ACS Trial).
- Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials.
- Left atrial structure and function in atrial fibrillation: ENGAGE AF-TIMI 48.
- Low-Dose Dopamine or Low-Dose Nesiritide in Acute Heart Failure With Renal Dysfunction: The ROSE Acute Heart Failure Randomized Trial.
- Edoxaban versus Warfarin in Patients with Atrial Fibrillation.
- The Year in Acute Coronary Syndrome.
- Heart failure: an update.
- Discharge Aspirin Dose and Clinical Outcomes in Patients with Acute Coronary Syndromes treated with Prasugrel vs. Clopidogrel: An Analysis from the TRITON-TIMI 38 Study.
- Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus.
- Age, treatment, and outcomes in high-risk non-ST-segment elevation acute coronary syndrome patients: Insights from the EARLY ACS trial.
- Circadian Variation of Stent Thrombosis and the Effect of More Robust Platelet Inhibition: A Post Hoc Analysis of the TRITON-TIMI 38 Trial.
- Reduction of Stent Thrombosis in Patients With Acute Coronary Syndromes Treated With Rivaroxaban in ATLAS-ACS 2 TIMI 51.
- Prevalence and clinical outcomes of undiagnosed diabetes mellitus and prediabetes among patients with high-risk non-ST-segment elevation acute coronary syndrome.
- Comparison of the Efficacy and Safety of Two Rivaroxaban Doses in Acute Coronary Syndrome (from ATLAS ACS 2-TIMI 51).
- Chronic heart failure: a look through the rear view mirror.
- Rivaroxaban in Patients Stabilized After a ST-Segment Elevation Myocardial Infarction: Results From the ATLAS ACS-2-TIMI-51 Trial (Anti-Xa Therapy to Lower Cardiovascu...
- Cardiac Troponin after Percutaneous Coronary Intervention and 1-Year Mortality in NSTE ACS Using Systematic Evaluation of Biomarker Trends.
- Incidence, treatment, and outcomes of atrial fibrillation complicating non-ST-segment elevation acute coronary syndromes.
- Vorapaxar in Patients With Peripheral Artery Disease: Results From TRA2{degrees}P-TIMI 50.
- Dynamic TIMI Risk Score for STEMI.
- Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: a randomized clinical trial.
- Efficacy and safety of vorapaxar in patients with prior ischemic stroke.
- Coronary plaque erosion: recognition and management.
- Cardiovascular science: opportunities for translating research into improved care.
- Effect of admission oral diuretic dose on response to continuous versus bolus intravenous diuretics in acute heart failure: An analysis from Diuretic Optimization Stra...
- The Year in Non-ST-Segment Elevation Acute Coronary Syndrome.
- Association Between Angiographic Complications and Clinical Outcomes Among Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: An EARL...
- Prospective evaluation of pregnancy-associated plasma protein-a and outcomes in patients with acute coronary syndromes.
- An Invasive or Conservative Strategy in Patients With Diabetes Mellitus and Non-ST-Segment Elevation Acute Coronary Syndromes: A Collaborative Meta-Analysis of Randomi...
- The rise of cardiovascular medicine.
- Early versus delayed, provisional eptifibatide in acute coronary syndromes.
- Thrombolysis in Myocardial Infarction (TIMI) Risk Index predicts long-term mortality and heart failure in patients with ST-elevation myocardial infarction in the TIMI ...
- Baseline hemoglobin concentration and creatinine clearance composite laboratory index improves risk stratification in ST-elevation myocardial infarction.
- Prognostic utility of apoB/AI, total cholesterol/HDL, non-HDL cholesterol, or hs-CRP as predictors of clinical risk in patients receiving statin therapy after acute co...
- Cytochrome p-450 polymorphisms and response to clopidogrel.
- Detection of acute changes in circulating troponin in the setting of transient stress test-induced myocardial ischaemia using an ultrasensitive assay: results from TIM...
- Rationale and design of IMPROVE-IT (IMProved Reduction of Outcomes: Vytorin Efficacy International Trial): comparison of ezetimbe/simvastatin versus simvastatin monoth...
- Greater clinical benefit of more intensive oral antiplatelet therapy with prasugrel in patients with diabetes mellitus in the trial to assess improvement in therapeuti...
- Reduction in recurrent cardiovascular events with prasugrel compared with clopidogrel in patients with acute coronary syndromes from the TRITON-TIMI 38 trial.
- Efficacy and safety of vorapaxar as approved for clinical use in the United States.
- Concomitant Use of Single Antiplatelet Therapy With Edoxaban or Warfarin in Patients With Atrial Fibrillation: Analysis From the ENGAGE AF-TIMI48 Trial.
- Platelet Inhibition With Ticagrelor 60 mg Versus 90 mg Twice Daily in the PEGASUS-TIMI 54 Trial.
- Reduction in Total Cardiovascular Events With Ezetimibe/Simvastatin Post-Acute Coronary Syndrome: The IMPROVE-IT Trial.
- Outcomes in Stable Patients With Previous Atherothrombotic Events Receiving Vorapaxar Who Experience a New Acute Coronary Event (from TRA2°P-TIMI 50).
Schools
New York University
Mt Sinai Hospital
Johns Hopkins Hospital
Bellevue Hospital Center
Conditions Treated
- Aortic Valve Disease
Doctors Specialties
- Cardiology
Accepted Insurances
Awards
- Elected Member
- Whos Who in Medicine and Healthcare
Education
-
Johns Hopkins University -
SUNY Health Science Center at Brooklyn -
Mount Sinai School of Medicine -
NYU School of Medicine
Hospital
-
Brigham and Women's Hospital
Helpful Reviews
Similar Doctors
|
Dr. Sammy Elmariah, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Alfonso H. Waller, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Antonio L. Perez, MD |
|
|
Dr. Dariush Mozaffarian, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Benjamin A. Olenchock, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ignacio Inglessis-Azuaje, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Susan Cheng, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Paul M. Ridker, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Mark A. Creager, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Karen E. Thomas, MD |
|
|
Dr. Themy F. Dumlao Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gregory A. Imbrie, MD |